questionsmedicales.fr
Virus
Virus à ARN
Retroviridae
Lentivirus
Lentivirus ovins-caprins
Virus maedi-visna
Virus maedi-visna : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Virus maedi-visna
Diagnostic médical
Tests de diagnostic
Virus maedi-visna
Symptômes
Virus maedi-visna
Virus maedi-visna
Infection virale
Diagnostic précoce
Virus maedi-visna
Symptômes
5
Symptômes
Virus maedi-visna
Symptômes neurologiques
Virus maedi-visna
Portage asymptomatique
Virus maedi-visna
Évolution des symptômes
Virus maedi-visna
Prévention
5
Prévention
Virus maedi-visna
Dépistage
Virus maedi-visna
Hygiène
Virus maedi-visna
Vaccination
Virus maedi-visna
Quarantaine
Virus maedi-visna
Traitements
5
Traitement
Virus maedi-visna
Antiviraux
Virus maedi-visna
Gestion des animaux
Virus maedi-visna
Vaccins
Virus maedi-visna
Nutrition
Virus maedi-visna
Complications
5
Complications
Virus maedi-visna
Fréquence des complications
Virus maedi-visna
Production animale
Virus maedi-visna
Complications irréversibles
Virus maedi-visna
Pronostic
Virus maedi-visna
Facteurs de risque
5
Facteurs de risque
Virus maedi-visna
Races animales
Virus maedi-visna
Environnement
Virus maedi-visna
Pratiques d'élevage
Virus maedi-visna
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus maedi-visna : Questions médicales les plus fréquentes",
"headline": "Virus maedi-visna : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus maedi-visna : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-20",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lentivirus ovins-caprins",
"url": "https://questionsmedicales.fr/mesh/D017972",
"about": {
"@type": "MedicalCondition",
"name": "Lentivirus ovins-caprins",
"code": {
"@type": "MedicalCode",
"code": "D017972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.589.600"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna",
"alternateName": "Visna-maedi virus",
"code": {
"@type": "MedicalCode",
"code": "D014790",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xujie Duan",
"url": "https://questionsmedicales.fr/author/Xujie%20Duan",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Xiaona Shi",
"url": "https://questionsmedicales.fr/author/Xiaona%20Shi",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Shuying Liu",
"url": "https://questionsmedicales.fr/author/Shuying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Stefán R Jónsson",
"url": "https://questionsmedicales.fr/author/Stef%C3%A1n%20R%20J%C3%B3nsson",
"affiliation": {
"@type": "Organization",
"name": "Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland."
}
},
{
"@type": "Person",
"name": "Yalçın Yaman",
"url": "https://questionsmedicales.fr/author/Yal%C3%A7%C4%B1n%20Yaman",
"affiliation": {
"@type": "Organization",
"name": "Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37356719",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.104956"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using genetics to explore complement C5 as a druggable protein in periodontitis.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39439802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1407431"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of multivalent complexes formed in the presence of more than one conventional antibody to terminal complement component C5.",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37079521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284502"
}
},
{
"@type": "ScholarlyArticle",
"name": "Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947526",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.77503"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39009967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12882-024-03662-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lentivirus",
"item": "https://questionsmedicales.fr/mesh/D016086"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lentivirus ovins-caprins",
"item": "https://questionsmedicales.fr/mesh/D017972"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus maedi-visna",
"item": "https://questionsmedicales.fr/mesh/D014790"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus maedi-visna - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus maedi-visna",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus maedi-visna",
"description": "Comment diagnostiquer une infection par le virus maedi-visna ?\nQuels tests sont utilisés pour le virus maedi-visna ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le virus chez les animaux asymptomatiques ?\nQuelle est l'importance du diagnostic précoce ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus maedi-visna",
"description": "Quels sont les symptômes principaux du virus maedi-visna ?\nLes symptômes varient-ils selon l'âge des moutons ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils toujours présents ?\nComment évoluent les symptômes au fil du temps ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus maedi-visna",
"description": "Comment prévenir l'infection par le virus maedi-visna ?\nLes tests de dépistage sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes animaux doivent-ils être vaccinés ?\nComment gérer les nouveaux animaux dans un troupeau ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus maedi-visna",
"description": "Quel est le traitement principal pour le virus maedi-visna ?\nPeut-on utiliser des antiviraux contre ce virus ?\nComment gérer les animaux infectés ?\nY a-t-il des vaccins disponibles ?\nQuel rôle joue la nutrition dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus maedi-visna",
"description": "Quelles complications peuvent survenir avec le virus maedi-visna ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles la production ?\nLes complications sont-elles réversibles ?\nQuel est le pronostic pour les animaux infectés ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus maedi-visna",
"description": "Quels sont les facteurs de risque d'infection ?\nLe stress augmente-t-il le risque d'infection ?\nLes races de moutons sont-elles affectées différemment ?\nL'environnement joue-t-il un rôle dans l'infection ?\nLes pratiques d'élevage influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Complement+C5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus maedi-visna ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des analyses PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus maedi-visna ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour identifier le virus dans le sang."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la pneumonie et l'encéphalite orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus chez les animaux asymptomatiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter le virus même sans symptômes visibles."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du diagnostic précoce ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce permet de mieux gérer la maladie et de limiter sa propagation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du virus maedi-visna ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, difficultés respiratoires et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge des moutons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes animaux peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes neurologiques comme des tremblements et des troubles de la coordination peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains animaux peuvent être porteurs sans montrer de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes au fil du temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver progressivement, menant à des complications graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus maedi-visna ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'isolement des animaux infectés et des pratiques d'élevage saines."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier des troupeaux permet de détecter et d'éliminer les animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes, comme le nettoyage des équipements, sont essentielles."
}
},
{
"@type": "Question",
"name": "Les animaux doivent-ils être vaccinés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il n'y ait pas de vaccin, la vaccination contre d'autres maladies est recommandée."
}
},
{
"@type": "Question",
"name": "Comment gérer les nouveaux animaux dans un troupeau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveaux animaux doivent être testés et mis en quarantaine avant d'intégrer le troupeau."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus maedi-visna ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antiviraux contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas d'antiviraux efficaces spécifiquement pour le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Comment gérer les animaux infectés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les animaux infectés doivent être isolés et traités symptomatiquement pour améliorer leur confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin commercialement disponible contre le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition peut aider à renforcer le système immunitaire des animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le virus maedi-visna ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie chronique et encéphalite, pouvant être mortelles."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications sont courantes chez les animaux infectés, surtout sans traitement."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la production ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la productivité des animaux, affectant la rentabilité de l'élevage."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles et graves."
}
},
{
"@type": "Question",
"name": "Quel est le pronostic pour les animaux infectés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le pronostic dépend de la gravité des symptômes; beaucoup développent des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le stress, et la densité de population dans le troupeau."
}
},
{
"@type": "Question",
"name": "Le stress augmente-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les races de moutons sont-elles affectées différemment ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines races peuvent être plus susceptibles à l'infection en raison de leur génétique."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement surpeuplé et insalubre favorise la propagation du virus."
}
},
{
"@type": "Question",
"name": "Les pratiques d'élevage influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques d'élevage inadéquates augmentent le risque de transmission du virus."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China. liushuying1968@imau.edu.cn.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Ege University Faculty of Science Department of Biology Molecular Biology Section, İzmir, Türkiye; Ege University Vaccine Development Application and Research Center, İzmir, Türkiye.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Norwegian Veterinary Institute, P.O. Box 64, 1431 Ås, Norway.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Norwegian Veterinary Institute, P.O. Box 64, 1431 Ås, Norway.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Anatomy and Physiology of Farm Animals, Department of Animal Science, Agricultural University of Athens (AUA), Iera Odos 75 str., 11855 Athens, Greece.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Anatomy and Physiology of Farm Animals, Department of Animal Science, Agricultural University of Athens (AUA), Iera Odos 75 str., 11855 Athens, Greece.
Publications dans "Virus maedi-visna" :
The human complement system plays a crucial role in immune defense. However, its erroneous activation contributes to many serious inflammatory diseases. Since most unwanted complement effector functio...
An excessively activated or dysregulated complement system has been proven to be a vital contributor to the pathogenesis of periodontitis. It has been previously hypothesized that inhibiting the activ...
In our primary analysis, we used 26 independent 'cis' single nucleotide polymorphisms as IVs from the vicinity of the encoding locus of C5 that are associated with plasma C5 levels. In a secondary ana...
In our primary approach, inhibiting C5 reduced the risk of periodontitis (Odds ratio 0.89 per 1 standard deviation reduction in C5; 95% confidence Interval 0.80-0.98,...
The findings from our study suggest that C5 inhibition may reduce the risk of periodontitis, prioritizing C5 inhibitors as a potential adjunctive therapeutic intervention in this disease....
This study sought to understand the nature of the immune complexes that could be formed when a patient is exposed simultaneously to two different anti-complement component 5 (C5) antibodies, such as i...
The membrane attack complex (MAC or C5b-9) is an important effector of the immune system to kill invading microbes. MAC formation is initiated when complement enzymes on the bacterial surface convert ...
No reports have shown histological changes before and after anti-C5 monoclonal antibody treatment in patients with atypical hemolytic uremic syndrome (aHUS). Here, we report a rare case of complement-...
A 53-year-old woman developed aHUS with CFH gene mutation [c.3572C > T (p. Ser1191 Leu)] and anti-CFH antibodies. Her father had succumbed to acute kidney injury (AKI) in his 30 s. She exhibited AKI, ...
This is the first report showing the pathophysiology of aHUS in the kidneys and the efficacy of anti-C5 monoclonal antibody treatment by presenting serial kidney pathological features before and after...
The efficacy and safety of complement inhibition in COVID-19 patients is unclear....
A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 patients with signs of systemic inflammation and hypoxemia (PaO...
81 patients were randomly assigned to zilucoplan (n = 55) or the control group (n = 26). 78 patients were included in the safety and primary analysis. Most were men (87%) and the median age was 63 yea...
Administration of zilucoplan to COVID-19 patients in this proof-of-concept randomized trial was well tolerated under antibiotic prophylaxis. While not reaching statistical significance, indicators of ...
The Phase 3 single-arm COMMODORE 3 study (ClinicalTrials.gov, NCT04654468) evaluated efficacy and safety of crovalimab (novel C5 inhibitor) in complement inhibitor-naive patients with paroxysmal noctu...
The complement system is an essential component of our innate defense and plays a vital role in the pathogenesis of many diseases. Assessment of complement activation is critical in monitoring both di...
We performed a systematic analysis of the current methods used to assess complement components and reviewed whether the identified studies performed their complement measurements according to the reco...
A literature search using the Pubmed/MEDLINE database was performed focusing on studies measuring the key complement components C3, C5 and/or their split products and/or the soluble variant of the ter...
A total of 92 out of 376 studies were selected for full-text analysis. Forty-five studies (49%) were identified as using the correct sample type and techniques for their complement analyses, while 25 ...
A substantial part of the reviewed studies did not use the appropriate sample type for assessing complement activation or did not mention which sample type was used. This deviation from the standardiz...
Several patients with myasthenia gravis (MG) do not adequately respond to available drugs or exhibit poor tolerance, necessitating the need for new therapies....
The paper discusses the rapidly evolving target-specific immunotherapies that promise long-standing remissions in the management of MG. It is specifically focused on the role of complement, anti-compl...
Anti-AChR antibodies cause internalization of the receptors and activate complement leading to...
C3 is a key complement protein, located at the nexus of all complement activation pathways. Extracellular, tissue, cell-derived, and intracellular C3 plays critical roles in the immune response that i...